MarketBeat on MSN
MannKind wins FDA approval for Afrezza in children, opening pediatric diabetes market
MannKind (NASDAQ:MNKD) said the U.S. Food and Drug Administration has approved Afrezza for pediatric patients with diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results